DAA药物选择路径讲课资料.pptVIP

当前已批DAA药物的;HCV确诊患者的治疗评估;索华迪?获批适应症;奥比帕利+达塞布韦钠获批适应症;达拉他韦＋阿舒瑞韦； 达拉他韦＋索华迪?获批适应症;达拉他韦＋阿舒瑞韦； 达拉他韦＋索华迪?获批适应症;索华迪?联合利巴韦林对基因1,2,3,6型 HCV均有高治愈率;索磷布韦的临床试验入组条件接近真实世界。亚洲国家的真实世界数据显示，其高治愈率（SVR12）与临床试验一致;索磷布韦片（索华迪?）说明书 奥比帕利片（维建乐?）说明书 盐酸达拉他韦片（百立泽?）简明处方;基因型 肝功能分期 RAVs检测 合并治疗;分数;Adapted from Asselah T, et al. J Hepatol 2014;61:193–5 2017 AASLD. IDSA. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. P37 ;AASLD/IDSA/IAS–USA. Recommendations for testing, managing, and treating hepatitis C.? . Accessed September 22, 2017;AASLD/IDSA/IAS–USA. Recommendations for testing, managing, and tr